Eli Lilly announced that it will refund 340B covered entities that purchased certain medications following adjustments to their ceiling prices. [...] …
Blog Posts
The Biden Administration has asked a federal appeals court to reconsider a Texas judge’s ruling that voided a Department of [...] …
Pfizer’s top executive told investors this week that the 340B program “is one of the biggest issues,” during an earnings [...] …
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Drugmakers Xellia Pharmaceuticals and Ascend Laboratories will refund 340B providers for some products following ceiling price recalculations, according to notices [...] …
After a long period in which many 340B providers felt helpless, the last month has brought two major wins. First, [...] …
340B INDUSTRY LEADER SPOTLIGHT
Julie Badger, Technical Training Advisor, Verity Solutions
Q: Where did you grow up?
Pleasanton, CA
Q: Where did you go to college/graduate school?
University of California Davis
Q: What are your favorites?
Food: I love to cook so it’s hard to pick one thing. My kids’ favorite home cooked meal is my Italian risotto recipe.
Movie: …
Kalderos, the drug industry vendor behind two 340B claims data submission platforms which support 340B rebates, will file an updated [...] …
A high-profile former Vermont governor with reported drug industry ties took aim at hospitals’ use of 340B savings, calling for [...] …
SPONSORED CONTENT
We understand that referrals are often the grayest area of your 340B program. That’s why we’ve been building technology and teams specifically focused on referral capture for more than a decade. As we engage with clients, we pay close attention to what
…